Premium
Parkinsonism and amiodarone therapy
Author(s) -
Werner Elke G.,
Olanow C. Warren
Publication year - 1989
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.410250618
Subject(s) - amiodarone , parkinsonism , medicine , basal ganglia , basal (medicine) , pharmacotherapy , anesthesia , cardiology , disease , central nervous system , atrial fibrillation , insulin
We report a case of reversible, dose‐related parkinsonian tremor in a patient taking amiodarone. In previous writings by others, basal ganglia dysfunction associated with amiodarone was dose related and reversibility was inversely related to duration of therapy. Patients receiving amiodarone are at risk for the development of basal ganglia dysfunction which may persist if the drug is not discontinued or the dosage reduced.